Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 28, 1996 - Issue 1
Submit an article Journal homepage
22
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Rubella Immunity and Morbidity: Impact of Different Vaccination Programs in Finland 1979–1992

Pentti Ukkonen Division of Infectious Diseases, Children's Hospital, and the Department of Virology, University of Helsinki, Helsinki, Finland
Pages 31-35 | Received 01 Sep 1995, Accepted 02 Nov 1995, Published online: 08 Jul 2009

References

  • McCollum RW, Randolph MF, Byrne EB, Hilleman MR. Rubella virus vaccine (HPV-77-DE 5). Am J Dis Child 1969; 118: 186–188
  • Plotkin SA, Farquhar JD, Katz M, Buser F. Attenuation of RA 27/3 rubella virus in WI-38 human diploid cells. Am J Dis Child 1969; 118: 178–185
  • Weibel RE, Carlson AJ, Villarejos VM, Buynak EB, McLean AA, Hilleman MR. Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus. Proc Soc Exp Biol Med 1980; 165: 323–326
  • Preblud SR, Serdula MK, Frank JA, Brandling-Bennett AD, Hinman AR. Rubella vaccination in the United States: a ten-year review. Epidemiol Rev 1980; 2: 171–194
  • Cutts FT, Zell ER, Mason D, Bernier RH, Dini EF, Orenstein WA. Monitoring progress toward US preschool immunization goals. JAMA 1992; 267: 1952–1955
  • Miller CL, Miller E, Waight PA. Rubella susceptibility and the continuing risk of infection in pregnancy. Br Med J 1987; 294: 1277–1278
  • Walker D, Carter H, Jones IG. Measles, mumps, and rubella: the need for a change in immunisation policy. Br Med J 1986; 292: 1501–1502
  • Peltola H, Karanko V, Kurki T, Hukkanen V, Virtanen M, Penttinen K, Nissinen M, Heinonen OP. Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet 1986; 1: 137–139
  • Paunio M, Virtanen M, Peltola H, Cantell K, Paunio P, Valle M, Karanko V, Heinonen OP. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland. Am J Epidemiol 1991; 133: 1152–1160
  • Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. N. Engl J Med 1994; 331: 1397–1402
  • Ukkonen P, von Bonsdorff C-H. Rubella immunity and morbidity: effects of vaccination in Finland. Scand J Infect Dis 1988; 20: 255–259
  • Ukkonen P, Hovi T, von Bonsdorff C-H, Saikku P, Penttinen K. Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: a computer analysis of 58,500 patients covering a period of eight years. J Med Virol 1984; 13: 131–148
  • Väänänen P, Vaheri A. Hemolysis-in-gel test in immunity surveys and diagnosis of rubella. J Med Virol 1979; 3: 245–252
  • Hedman K, Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 1988; 8: 214–221
  • Brunell PA, Weigle K, Murphy MD, Shehab Z, Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 1983; 250: 1409–1412
  • Vesikari T, Ala-Laurila E-L, Heikkinen A, Terhc A, D'Hondt E, André FE. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. Am J Dis Child 1984; 138: 843–847
  • Witte JJ, Karchmer AW, Case G, Herrmann KL, Abrutyn E, Kassanoff I, Neill JS. Epidemiology of rubella. Am J Dis Child 1969; 118: 107–111
  • Redd SC, Wharton M, Hadler SC, Orenstein WA. The measles-mumps-rubella vaccination program in Finland. N Engl J Med 1995; 332: 1102–1103
  • Munro ND, Wild NJ, Sheppard S, Smithells RW, Hambling MH. Fall and rise of immunity to rubella. Br Med J 1987; 294: 481
  • Miller E. The new measles campaign. Br Med J 1994; 309: 1102–1103
  • Christenson B, Böttiger M, Heller L. Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience. Br Med J 1983; 287: 389–391
  • Carter H, Gorman D. Measles, mumps, and rubella vaccine: time for a two stage policy?. Br Med J 1992; 304: 637
  • Anderson RM, May RM. Immunisation and herd immunity. Lancet 1990; 1: 641–645
  • Babad HR, Nokes DJ, Gay NJ, Miller E, Morgan-Capner P, Anderson RM. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect 1995; 114: 319–344
  • The vaccinator's Manual (in Finnish), H Nohynek, E Pekkanen, J Eskola. Kustannus Oy Duodecim, Helsinki 1993
  • Huygelen C, Sigel MM, Zygraich N, Peetermans JH, Colinet G, Leyten R, Raupp WG, Pinto CA, Garg SG, Boyle JJ, Haff RF. Safety testing of rubella virus vaccine (Cendehill strain). Am J Dis Child 1969; 118: 362–366

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.